Use of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: A prospective 6-month study

Diabetes Care

Volumn 34, Issue 3, 2011, Pages 574-579

  Garg, Satish K ^a   Voelmle, Mary K ^a   Beatson, Christie R ^a   Miller, Hayley A ^a   Crew, Lauren B ^a   Freson, Brandon J ^a   Hazenfield, Rachel M ^a  

^a UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DIABETES CONTROL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG SAFETY; EDEMA; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INJECTION SITE CONTUSION; INJECTION SITE ERYTHEMA; INJECTION SITE INFECTION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 79956157918     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1852     Document Type: Article

References (22)

1. Nathan DM, Cleary PA, Backlund JY, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/ EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005;353:2643-2653
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986
3. Chase HP, Roberts MD, Wightman C, et al. Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003;111:790-794 (Pubitemid 36402903)
4. Ludvigsson J, Hanas R. Continuous subcutaneous glucose monitoring improved metabolic control in pediatric patients with type 1 diabetes: a controlled crossover study. Pediatrics 2003;111:933-938 (Pubitemid 36542603)
5. Tanenberg R, Bode B, Lane W, et al. Use of the continuous glucose monitoring system to guide therapy in patients with insulin-treated diabetes: a randomized controlled trial. Mayo Clin Proc 2004;79: 1521-1526 (Pubitemid 39578876)
6. Tamborlane WV, Beck RW, Bode BW, et al.; Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 2008;359:1464-1476
7. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring ( JDRF-CGM) trial. Diabetes Care 2010;33:17-22
8. Deiss D, Bolinder J, Riveline JP, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006;29:2730-2732 (Pubitemid 44912209)
9. Bode BW, Gross TM, Thornton KR, Mastrototaro JJ. Continuous glucose monitoring used to adjust diabetes therapy improves glycosylated hemoglobin: a pilot study. Diabetes Res Clin Pract 1999;46: 183-190
10. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care 2004;27:734-738 (Pubitemid 38280542)
11. Garg S, Zisser H, Schwartz S, et al. Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006;29:44-50 (Pubitemid 44033429)
12. Garg SK, Kelly WC, Voelmle MK, et al. Continuous home monitoring of glucose: improved glycemic control with real-life use of continuous glucose sensors in adult subjects with type 1 diabetes. Diabetes Care 2007;30:3023-3025 (Pubitemid 350255236)
13. Rodbard D, Jovanovic L, Garg S. Responses to continuous glucose monitoring in patients with type 1 diabetes using multiple daily injections and insulin pumps. Diabetes Technol Ther 2009;11:757-765
14. Moser EG, Crew LB, Garg SK. Role of continuous glucose monitoring in diabetes management. Avances en Diabetologia 2010;26:73-79
15. Jenkins AJ, Krishnamurthy B, Best JD, et al. Evaluation of an algorithmto guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial. Diabetes Care 2010;33:1242-1248
16. Hirsch IB. Algorithms for care in adults using continuous glucose monitoring. J Diabetes Sci Tech 2007;1:126-129
17. Rodbard D, Bailey T, Jovanovic L, Zisser H, Kaplan R, Garg SK. Improved quality of glycemic control and reduced glycemic variability with use of continuous glucose monitoring. Diabetes Technol Ther 2009; 11:717-723
18. Bergenstal RM, Tamborlane WV, Ahmann A, et al.; STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311-320
19. Hill NR, Hindmarsh PC, Stevens RJ, Stratton IM, Levy JC, Matthews DR. A method for assessing quality of control from glucose profiles. Diabet Med 2007; 24:753-758 (Pubitemid 47012121)
20. Garg SK. The future of continuous glucose monitoring. Diabetes Technol Ther 2009; 11(Suppl. 1):S1-S3
21. Garg SK. Role of continuous glucose monitoring in patientswith diabetes using multiple daily insulin injections. Infusystems USA 2009;6:9-14
22. Blevins TC, Bode BW, Garg SK, et al.; AACE Continuous Monitoring Task Force. Statement by the American Association of Clinical Endocrinologists Consensus Panel on continuous glucose monitoring. Endocr Pract 2010;16:730-745